DISINFACTS | Issue 2/2020

INTERVIEW THANK YOU to all those who, especially in clinics, nursing homes, practices, laboratories and industrial operations help us all get through this crisis in the best possible way. Your BODE Chemie GmbH & PAUL HARTMANN AG The quality of our products will continue to be unaffected by new packaging elements. We are also considering, for example, supplying Sterillium in large containers known as intermediate bulk containers with 1000 litre capacity. Qualified professionals such as pharmacists or pharmacy technical assistants in hospitals or aged care facilities can then fill empty bottles themselves. This is because we know from experience that during an epidemic there will be shortages not of the disinfectant itself but rather of the packaging. Our employees in the BODE SCIENCE CENTER are currently putting together all the important information about handling disinfectants in large containers for our customers. Many companies outside the sector are currently manufacturing disinfectants. What criteria does a disinfectant have to meet to be able to successfully inactivate the novel coronavirus? Most companies focus on the formulations released by the WHO and the Federal Institute for Occupational Health and Safety in Germany. During a crisis like the current one, these formulations help to maintain the supply of disinfectants. Regarding our skincare complex, these formulations are, however, considerably simpler than the Sterillium products. To inactivate SARS-CoV-2, all disinfectants that are active against enveloped viruses work, that is, all those with a spectrum of activity of ‘virucidal’, ‘limited virucidal’ or ‘limited virucidal PLUS’. All the disinfectants that we produce, such as those in the Sterillium and the Sterillium Protect & Care range, can be used for effective inactivation of the novel coronavirus SARS-CoV-2. DISINFACTS 2/20 page 11